South Africa considers pharma patent changes
After several years of relative calm, pharmaceutical patents are in the spotlight again in South Africa, with a new Draft IP Policy launched. Russell Bagnall and Dario Tanziani explain why it has been introduced, and discuss the changes proposed
Access to medicines, and the role that the patent system
plays in preventing such access, became the subject of debate
several years ago in South Africa. In the early 2000s, and at a
time when the HIV-AIDS pandemic reached very...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.